CCL4 and melanoma: Some of the MRs associated with the ICR-L phenotype lead to significant enrichment of the \documentclass[12pt]{minimal}\usepackage{amsmath}\usepackage{wasysym}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{amsbsy}\usepackage{upgreek}\usepackage{mathrsfs}\setlength{\oddsidemargin}{-69pt}\begin{document}}{}$\beta $\end{document}-catenin pathway, whose signaling was known to prevent antitumor immunity in melanoma [56] and other tumors [40] and was associated with an immune-silent phenotype due to lack of CCL4 mediated chemotaxis of effector cells.